Nurix Therapeutics, Inc. (NRIX)
26.21
-0.66
(-2.47%)
USD |
NASDAQ |
Aug 28, 16:00
26.19
-0.02
(-0.08%)
After-Hours: 20:00
Nurix Therapeutics Stock Buybacks (Quarterly) : -0.066M for May 31, 2026
Stock Buybacks (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.066M |
| February 28, 2026 | -19.98M |
| November 30, 2025 | -236.01M |
| August 31, 2025 | -1.155M |
| May 31, 2025 | -0.006M |
| February 28, 2025 | -1.473M |
| November 30, 2024 | -200.52M |
| August 31, 2024 | -45.77M |
| May 31, 2024 | -237.75M |
| February 29, 2024 | -1.624M |
| November 30, 2023 | -0.007M |
| August 31, 2023 | -1.704M |
| May 31, 2023 | -0.025M |
| February 28, 2023 | -1.481M |
| November 30, 2022 | 0.135M |
| Date | Value |
|---|---|
| August 31, 2022 | -115.41M |
| May 31, 2022 | -0.432M |
| February 28, 2022 | -1.488M |
| November 30, 2021 | -0.50M |
| August 31, 2021 | -1.552M |
| May 31, 2021 | -150.47M |
| February 28, 2021 | -1.359M |
| November 30, 2020 | 1.126M |
| August 31, 2020 | -220.42M |
| May 31, 2020 | -119.68M |
| February 29, 2020 | -0.046M |
| November 30, 2019 | -0.08M |
| August 31, 2019 | 0.007M |
| May 31, 2019 | -0.046M |
| February 28, 2019 | -0.007M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Stock Buybacks (Quarterly) Benchmarks
| Monte Rosa Therapeutics, Inc. | -3.211M |
| Gilead Sciences, Inc. | 346.00M |
| TG Therapeutics, Inc. | -0.085M |
| Cue Biopharma, Inc. | -30.02M |
| Keros Therapeutics, Inc. | -0.023M |